sur The Vanguard Group, Inc. (isin : US12572Q1058)
Vanguard Group Discloses Stake in Avadel Pharmaceuticals
The Vanguard Group, Inc. has filed a Form 8.3 regarding its interests in Avadel Pharmaceuticals plc. As per the disclosure, Vanguard holds 5,580,709 US$0.01 ordinary shares, representing a 5.73% stake in Avadel. This position was last updated on December 5, 2025, indicating that no additional parties were involved in this disclosure. The document outlines Vanguard's current interests and short positions in Avadel's securities.
The filing also disclosed recent transactions involving these shares. Vanguard purchased 4,149 shares and sold 4,737 shares at a price of 21.34 USD per unit. No other dealings such as options or derivative agreements have been reported in this filing. Additionally, the form states there are no indemnity or other dealing arrangements, nor any agreements on voting rights related to the disclosed securities.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.